hydroxyindoleacetic acid has been researched along with Encephalomyopathies, Mitochondrial in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A patient with Lafora disease reported enough improvement in myoclonus-evoked convulsions to continue chronic use of the drug." | 2.68 | Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan. ( Ashwal, S; Bodensteiner, J; Franz, D; Haas, RH; Huang, Y; Pranzatelli, MR; Tate, E, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pranzatelli, MR | 1 |
| Tate, E | 1 |
| Huang, Y | 1 |
| Haas, RH | 1 |
| Bodensteiner, J | 1 |
| Ashwal, S | 1 |
| Franz, D | 1 |
1 trial available for hydroxyindoleacetic acid and Encephalomyopathies, Mitochondrial
| Article | Year |
|---|---|
Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Cross-Over Studies; Double-Blind Method; Drug The | 1995 |